Novus Therapeutics, Inc. Contracts & Agreements
86 Contracts & Agreements
- Business Finance (29 contracts)
- Business Operations (7)
- Human Resources (26)
- Intellectual Property (3)
- Real Estate (6)
- Uncategorized (15)
- Form of Pre-Funded Warrant (Filed With SEC on October 30, 2024)
- Underwriting Agreement, dated October 29, 2024, by and between Eledon Pharmaceuticals, Inc. and Leerink Partners LLC, as representative of the several underwriters named therein (Filed With SEC on October 30, 2024)
- Eledon Pharmaceuticals, Inc. 2020 Long Term Incentive Plan, as amended (Filed With SEC on July 10, 2024)
- Registration Rights Agreement, dated May 6, 2024 (Filed With SEC on May 7, 2024)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on May 7, 2024)
- Securities Purchase Agreement, dated May 6, 2024 (Filed With SEC on May 7, 2024)
- Form of Stock Option Agreement, dated May 1, 2023, between Eledon Pharmaceuticals, Inc. and each of David-Alexandre C. Gros, M.D., Steve Perrin, Ph D. and Paul Little (Filed With SEC on March 28, 2024)
- Form of Amendment to Stock Option Agreement, dated December 30, 2023, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D., Steve Perrin, Ph D. and Paul Little (Filed With SEC on March 28, 2024)
- Form of Indemnification Agreement to be entered into with each of the directors and officers of Eledon (Filed With SEC on September 21, 2023)
- Eledon Pharmaceuticals, Inc. 2020 Long Term Incentive Plan, as amended (Filed With SEC on June 22, 2023)
- License Agreement between Lonza Sales AG and Anelixis Therapeutics, LLC, dated September 11, 2018 (Filed With SEC on August 11, 2022)
- First Amendment to Restated License Agreement between ALS Therapy Development Foundation, Inc. and Anelixis Therapeutics, Inc. dated September 5, 2020 (Filed With SEC on August 11, 2022)
- Amended and Restated License Agreement by and between ALS Therapy Development Foundation, Inc. and Anelixis Therapeutics, Inc, dated February 18, 2020 (Filed With SEC on August 11, 2022)
- SUBLEASE AGREEMENT BY AND BETWEEN CORPORATE TECHNOLOGIES, INC., SUBLANDLORD AND ELEDON PHARMACEUTICALS, INC., SUBTENANT A PORTION OF 78 Blanchard Road, Burlington, MA 01803... (Filed With SEC on March 24, 2022)
- SECOND AMENDMENT TO LEASE (Filed With SEC on March 24, 2022)
- ELEDON PHARMACEUTICALS, INC. Stock Option Agreement Granted Under 2020 Long Term Incentive Plan (Filed With SEC on March 24, 2022)
- Series X1 Exchange Agreement, dated January 11, 2022, by and among Eledon Pharmaceuticals, Inc. and the Stockholders named therein (Filed With SEC on January 13, 2022)
- Open Market Sales Agreement by and between the Registrant and Jefferies, LLC dated March 30, 2021 (Filed With SEC on March 31, 2021)
- Novus Therapeutics, Inc., 2020 Long Term Incentive Plan (Filed With SEC on March 31, 2021)
- Executive Employment Agreement, dated March 15, 2021, between Eledon Pharmaceuticals, Inc. and Paul Little (Filed With SEC on March 31, 2021)
- Executive Employment Agreement, dated March 1, 2021, between Eledon Pharmaceuticals, Inc. and Jon Kuwahara (Filed With SEC on March 31, 2021)
- Executive Employment Agreement, dated September 9, 2020, between Novus Therapeutics, Inc. and David-Alexandre C. Gros, M.D (Filed With SEC on March 31, 2021)
- Description of Securities (Filed With SEC on March 31, 2021)
- Warrant Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on January 7, 2021)
- Series X Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on January 7, 2021)
- Description of Securities (Filed With SEC on March 17, 2020)
- Exchange Agreement, dated February 13, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on February 19, 2020)
- Form of Warrant Exercise Agreement by and between Novus Therapeutics, Inc. and the Holders named therein (Filed With SEC on January 16, 2020)
- Form of Private Placement Warrant (Filed With SEC on January 16, 2020)
- Management Continuity Agreement, date August 7, 2017, between Novus Therapeutics, Inc. and Catherine C. Turkel (Filed With SEC on May 14, 2019)
- Form of Warrant (Filed With SEC on May 2, 2019)
- Form of Placement Agent Warrant (Filed With SEC on May 2, 2019)
- Form of Securities Purchase Agreement, dated April 30, 2019, by and between Novus Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on May 2, 2019)
- Executive Employment Agreement, dated November 10, 2015, between Otic Pharma, Inc. and Catherine C. Turkel (Filed With SEC on March 28, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 4, 2018)
- First Amendment to Lease Agreement, dated April 9, 2018, by and between The Irvine Company LLC and Novus Therapeutics, Inc (Filed With SEC on August 7, 2018)
- Novus Therapeutics, Inc., 2014 Stock Incentive Plan (Filed With SEC on August 7, 2018)
- Novus Therapeutics, Inc., 2014 Employee Stock Purchase Plan (Filed With SEC on August 7, 2018)
- Tokai Pharmaceuticals, Inc. 2014 Stock Incentive Plan (Filed With SEC on April 2, 2018)
- Tokai Pharmaceuticals, Inc. 2007 Stock Incentive Plan (Filed With SEC on April 2, 2018)
- Otic Pharma Ltd. Global Share Incentive Plan (2012) (Filed With SEC on April 2, 2018)
- NOVUS THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Equity Distribution Agreement (Filed With SEC on August 22, 2017)
- NOVUS THERAPEUTICS, INC. MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on August 9, 2017)
- NOVUS THERAPEUTICS, INC. MANAGEMENT CONTINUITY AGREEMENT (Filed With SEC on August 9, 2017)
- Pursuant to 17 CFR 20.24b-2, confidential information has been omitted in places marked ***and has been filed separately with the Securities and Exchange Commission pursuant to a... (Filed With SEC on August 9, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2017)
- LEASE BETWEEN THE IRVINE COMPANY LLC AND OTIC PHARMA, INC. LEASE (Short Form) (Filed With SEC on August 9, 2017)
- INDEMNIFICATION AGREEMENT (Filed With SEC on August 9, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 15, 2017)
- AMENDED AND RESTATED SHARE PURCHASE AGREEMENT by and among TOKAIPHARMACEUTICALS, INC., OTIC PHARMA, LTD. and SHAREHOLDERS OFOTIC PHARMA, LTD. Dated as of March 2, 2017 Effective... (Filed With SEC on March 3, 2017)
- TOKAI PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on February 3, 2017)
- SHARE PURCHASE AGREEMENT by and among TOKAIPHARMACEUTICALS, INC., OTIC PHARMA, LTD. and SHAREHOLDERS OFOTIC PHARMA, LTD. Dated as of December 21, 2016 TABLE OF CONTENTS (Filed With SEC on December 22, 2016)
- SUPPORT AGREEMENT (Filed With SEC on December 22, 2016)
- CONSULTING AGREEMENT (Filed With SEC on November 3, 2016)
- CONSULTING AGREEMENT (Filed With SEC on November 3, 2016)
- TOKAI PHARMACEUTICALS, INC. CONSULTING AGREEMENT (Filed With SEC on November 3, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 10, 2016)
- - 2 - (Filed With SEC on August 12, 2015)
- 255 STATE STREET BOSTON, MASSACHUSETTS LEASE by and between 255 STATE STREET, LLC as Landlord and TOKAI PHARMACEUTICALS,INC. as Tenant dated as of May 29, 2015 255 STATE STREET... (Filed With SEC on August 12, 2015)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 12, 2015)
- AMENDMENT TO EMPLOYMENT LETTER (Filed With SEC on March 26, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 26, 2015)
- SUBLEASE (Filed With SEC on March 26, 2015)
- AMENDMENT TO EMPLOYMENT LETTER (Filed With SEC on March 26, 2015)
- AMENDMENT TO EMPLOYMENT LETTER (Filed With SEC on March 26, 2015)
- AMENDMENT TO EMPLOYMENT LETTER (Filed With SEC on March 26, 2015)
- [ ] Shares TOKAI PHARMACEUTICALS, INC. Common Stock UNDERWRITINGAGREEMENT (Filed With SEC on September 2, 2014)
- TOKAI PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on September 2, 2014)
- PLEASE INSERT SOCIAL SECURITY OR OTHER (Filed With SEC on September 2, 2014)
- TOKAI PHARMACEUTICALS, INC. 2014 STOCK INCENTIVE PLAN (Filed With SEC on September 2, 2014)
- TOKAI PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on September 2, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 2, 2014)
- - 2 - (Filed With SEC on September 2, 2014)
- TOKAI PHARMACEUTICALS, INC. 2014EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on September 2, 2014)
- - 2 - (Filed With SEC on August 11, 2014)
- - 2 - (Filed With SEC on August 11, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. MASTER LICENSE AGREEMENT BETWEEN UNIVERSITY... (Filed With SEC on August 11, 2014)
- - 2 - (Filed With SEC on August 11, 2014)
- - 2 - (Filed With SEC on August 11, 2014)
- - 2 - (Filed With SEC on August 11, 2014)
- - 2 - (Filed With SEC on August 11, 2014)
- - 1 - (Filed With SEC on August 11, 2014)
- TOKAI PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under 2007 Stock Incentive Plan (Filed With SEC on August 11, 2014)
- TOKAI PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2007 Stock Incentive Plan (Filed With SEC on August 11, 2014)
- TOKAI PHARMACEUTICALS, INC. 2007 STOCK INCENTIVE PLAN (Filed With SEC on August 11, 2014)
- FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 11, 2014)
